Amgen profit slips, sales target cut
BOSTON (MarketWatch) -- Amgen Inc. reported late Thursday first-quarter net income fell 7% and the drug maker cut its sales view for the year as the global economic downturn cut into amount of money being spent on medication.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here